Key Quantitative Figures
- Zero (0) equity shares tendered in dematerialized form, constituting 0% of the offer size
- Zero (0) equity shares tendered in physical form, constituting 0% of the offer size
- Total offer size: 64,19,608 fully paid-up equity shares of face value ₹5 each
- Offer represents 26% of the voting share capital of Novartis India Limited
Dates of Action
- Disclosure date: June 15, 2026
- Tender date: June 15, 2026
- Letter of Offer dated: June 1, 2026
Parties Involved
Acquirers:
- WaveRise Investments Limited (Acquirer 1)
- ChrysCapital Fund X, the first scheme of ChrysCapital Trust I (Acquirer 2)
- Two Infinity Partners (Acquirer 3)
Persons Acting in Concert (PACs):
- ChrysCapital X, LLC (PAC 1)
- OceanEdge Investments Limited (PAC 2)
Service Providers:
- Manager to the Open Offer: Axis Capital Limited
- Registrar to the Open Offer: Not named in disclosure
- Depository Participant: Ventura Securities Limited (DP ID: IN303116)
- Open Offer Escrow Demat Account: MIIPL NOVARTIS INDIA LIMITED OPEN OFFER ESCROW DEMAT ACCOUNT (Client ID: 15855051, PAN: AAACH2914F)
Process Details
Equity shares tendered by public shareholders are subject to validation and verification of complete document submission. The number of shares 'validly tendered' and ultimately accepted may differ from the initial tender figures disclosed. Final acceptance will be in accordance with SEBI (SAST) Regulations and the Letter of Offer.
Capital Structure Impact
The open offer, if successful, would result in the acquirers obtaining up to 26% of Novartis India's voting share capital from public shareholders.